Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Dose Finding Study on BI54903 (Inhaled Corticosteroid) Administered Twice Daily Via RespimatĀ® Inhaler in Asthmatic Patients Inadequately Controlled on Short-acting-beta-agonist (SABA) Therapy
BI 54903
1248.5
NCT01397162
Asthma
Phase 2
 
April 2017

Powered by ideaPoint, Inc.